ZOETIS INC.
ZTSZoetis Inc. (ZTS) is a global leader in animal health, providing a wide range of pharmaceutical, vaccine, and diagnostic products for livestock and companion animals. Established in 1952 and becoming an independent company in 2013, Zoetis develops innovative solutions to improve animal health and well-being, supporting the needs of veterinarians, pet owners, and livestock producers worldwide.
Dividend History
Investors can expect a dividend payout of $0.53 per share, scheduled to be distributed in 39 days on March 3, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| March 3, 2026 | $0.53 | 2026-01-20 | 2026-01-20 |
| December 2, 2025 | $0.50 | 2025-10-31 | 2025-10-31 |
| September 3, 2025 | $0.50 | 2025-07-18 | 2025-07-18 |
| June 3, 2025 | $0.50 | 2025-04-21 | 2025-04-21 |
| March 4, 2025 | $0.50 | 2025-01-21 | 2025-01-21 |
Dividends Summary
- Consistent Payer: ZOETIS INC. has rewarded shareholders with 52 dividend payments over the past 13 years.
- Total Returned Value: Investors who held ZTS shares during this period received a total of $11.64 per share in dividend income.
- Latest Payout: The most recent dividend of $0.53/share was paid 52 days ago, on December 2, 2025.
- Yield & Schedule: ZTS currently pays dividends quarterly with an annual yield of 1.64%.
- Dividend Growth: Since 2013, the dividend payout has grown by 715.4%, from $0.07 to $0.53.
- Dividend Reliability: ZTS has maintained or increased its dividend for 50 consecutive payments.
Company News
The global canine vaccines market is projected to grow from USD 2.05 billion in 2025 to USD 3.45 billion by 2033, with a CAGR of 6.79%. Growth is driven by rising pet ownership, increased awareness of preventive animal healthcare, and higher veterinary spending. Core vaccines and rabies vaccines lead by market share, while combination vaccines an...
The global diesel generator market is projected to grow at a CAGR of 5.28% from 2026 to 2032, reaching USD 27.42 billion by 2032 from USD 18.17 billion in 2024. Growth is driven by industrialization, infrastructure development, rising power outages, and data center expansion. However, the market faces headwinds from stringent environmental regula...
The article highlights two dividend stocks, AbbVie and Zoetis, as excellent long-term investment options due to their stable business models, consistent revenue generation, and impressive dividend growth track records.
The global companion animal health market is projected to grow from USD 25.28 billion in 2024 to USD 61.74 billion by 2034, driven by rising pet ownership, pet humanization trends, and advances in veterinary technologies.
The global pet cancer therapeutics market is projected to grow from $493 million in 2025 to $1.15 billion by 2034, driven by increasing pet cancer awareness, advanced veterinary treatments, and growing pet humanization trends.
